Kayla Coulombe

About Kayla Kayla hails from Nipissing University’s BScN program. She began her student experience as an RPN in the role of a volunteer Research Nurse with us in November of 2018.

Read More

Osteoarthritis of the Knee (BP-2020-G001-P2)

This trial is a Phase 2 Multicenter, Double-blind, Randomized, Parallel-Group, Vehicle- Controlled Study to Evaluate the Efficacy, Safety, and Local Tolerability of G001 in Patients with Osteoarthritis (OA) of the Knee. The objectives of this study are to explore the efficacy, safety, and local tolerability of G001 compared to vehicle in patients with symptomatic osteoarthritis…

Read More

Biogen – 230LE301/302 – Lupus

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Manifestations. Register Today!

Read More

Single-use Testosterone in Healthy Participants (PK Study)

The purpose of this work is to investigate the dose-response curve for intranasal testosterone in healthy young men and women. A large body of evidence has investigated links between baseline levels of testosterone and individual differences in human dominance behaviour, including behaviours that are intended to obtain or maintain a high social rank or status…

Read More

Atopic Dermatitis (I4V-MC-JAIX)

Atopic dermatitis (AD) is a pruritic, chronic or chronically relapsing, highly symptomatic inflammatory skin disease characterized by excessive T cell activation leading to significant skin infiltration by T cells and dendritic cells (Bieber 2010). Presentation is varied, but includes skin manifestations and pruritus, with associated sleep disturbances and subsequent skin infections. The course of disease…

Read More

Pneumococcal Conjugate Vaccine in Healthy Infants (B7471013)

A phase 3, randomized, double-blind trial to evaluate the safety of a 20-valent pneumococcal conjugate vaccine in healthy infants at investigator sites in the United States and potentially other countries to be determined. This study is part of the Phase 3 clinical development program to support the use of 20vPnC in the pediatric population. The…

Read More

Ulcerative Colitis (ABI-M201-101)

A randomized, double-blind, placebo-controlled, multi-center Phase 1b study to evaluate the safety, efficacy and microbiological response of orally administered ABI-M201 in subjects with mildly-to-moderately active Ulcerative Colitis with ongoing Mesalamine treatment. Register Today!

Read More

Palmoplantar Psoriasis (ANB019-003)

A Phase II, randomized, placebo-controlled, double-blind, multiple dose study to evaluate the Efficacy and Safety of ANB019 in subjects with Palmoplantar Pustulosis. Register Today!

Read More